The global minimally invasive thoracic surgery market size is expected to reach USD 5.5 billion by 2028, according to the report. It is expected to expand at a CAGR of 8.7% from 2021 to 2028. Minimally Invasive Surgery (MIS) is gaining popularity owing to the reduced risk and trauma associated with these procedures as small incisions decrease post-operative pain that facilitates a speedy recovery.
Increasing research and development in this field is another high-impact rendering driver of the market. The introduction of novel technologies and devices by the market players has been observed in recent years. In the U.S., lung cancer is the second leading cancer form. According to the American Cancer Society, about 235,760 new lung cancer cases are estimated in 2021. A high number of smokers in the U.S. is a leading cause of cancer prevalence in the region.
Smoking is also one of the major risk factors for lung cancer in developing countries. Nearly 80% of smokers live in middle and low-income countries. This makes developing countries a potential market for thoracic surgeries. Reduction in elective surgeries, concerns related to virus proliferation, and reduced hospital staffs are factors triggered by the COVID-19 outbreak in 2020. However, the market is said to improve by Q2 of 2022.
This product will be delivered within 1-3 business days.
Increasing research and development in this field is another high-impact rendering driver of the market. The introduction of novel technologies and devices by the market players has been observed in recent years. In the U.S., lung cancer is the second leading cancer form. According to the American Cancer Society, about 235,760 new lung cancer cases are estimated in 2021. A high number of smokers in the U.S. is a leading cause of cancer prevalence in the region.
Smoking is also one of the major risk factors for lung cancer in developing countries. Nearly 80% of smokers live in middle and low-income countries. This makes developing countries a potential market for thoracic surgeries. Reduction in elective surgeries, concerns related to virus proliferation, and reduced hospital staffs are factors triggered by the COVID-19 outbreak in 2020. However, the market is said to improve by Q2 of 2022.
Minimally Invasive Thoracic Surgery Market Report Highlights
- By type, lobectomy dominated the market in 2020. Lobectomy procedure involves the removal of an entire lobe of the lung in cases of stage one non-small cell lung cancer (NSCLC). It is preferred over the limited resections as a large portion is removed, thereby decreasing the risk of recurrence in the local area
- There is a trend of increasing the adoption of minimally invasive techniques in other types of thoracic surgeries, such as sleeve lobectomy, segmentectomy, and thoracic sympathectomy. Technological advancements such as better imaging technology through improved optics for video thoracoscopes are fueling the growth
- North America held the largest revenue share in 2020 and is expected to maintain its position during the forecast period. This is on account of the high prevalence of the target disorder, high smoking traits in the population, and significant funding involved in the research involving solutions to lung cancer
- The availability of technologically advanced surgical methods with better surgeon expertise is expected to fuel the market growth in North America
- Asia Pacific is expected to witness the fastest growth in the coming years due to the rapid adoption of technology and growing awareness regarding the target disorders
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope1.1. Market Segmentation & Scope
1.1.1. Type
1.1.2. Regional scope
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. Internal Database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1: Understanding trends and variables in the individual countries and their impact on growth
1.9.2. Objective 2: Understanding market estimates and forecasts
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type
2.2.2. Regional outlook
2.3. Competitive Insights
Chapter 3. Minimally Invasive Thoracic Surgery Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Regulatory framework
3.3.2. Reimbursement pathway
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Preference to Minimally Invasive Procedures
3.4.1.2. Rise in Prevalence of Chronic Diseases
3.4.1.3. Rapid Technological Advancements and Introduction of New Products Increasing expenditure on R&D by industry players
3.4.2. Market restraint analysis
3.4.2.1. Uncertainty in regulatory reforms
3.4.2.2. High cost of surgeries
3.5. Minimally Invasive Thoracic Surgery: Market Analysis Tools
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Supplier power (High)
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies
Chapter 4. Minimally Invasive Thoracic Surgery Market: Segment Analysis, By Type, 2016 - 2028 (USD Million)
4.1. Definitions and Scope
4.1.1. Lobectomy
4.1.2. Wedge Resection
4.1.3. Pneumonectomy
4.1.4. Others
4.2. Type Market Share, 2020 & 2028
4.3. Segment Dashboard
4.4. Global Minimally Invasive Thoracic Surgery Market, by Type, 2016 to 2028
4.5. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
4.5.1. Lobectomy
4.5.1.1. Lobectomy based Market estimates and forecast 2016 to 2028 (USD Million)
4.5.2. Wedge Resection
4.5.2.1. Wedge Resection based Market estimates and forecast 2016 to 2028 (USD Million)
4.5.3. Pneumonectomy
4.5.3.1. Pneumonectomy based Market estimates and forecast 2016 to 2028 (USD Million)
4.5.4. Others
4.5.4.1. Others based Market estimates and forecast 2016 to 2028 (USD Million)
Chapter 5. Minimally Invasive Thoracic Surgery Market: Regional Estimates & Trend Analysis
5.1. Regional market share analysis, 2020 & 2028
5.2. Regional Market Dashboard
5.3. Global Regional Market Snapshot
5.4. Regional Market Share and Leading Players, 2020
5.4.1. North America
5.4.2. Europe
5.4.3. Asia Pacific
5.4.4. Latin America
5.4.5. Middle East and Africa
5.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
5.5.1. North America
5.5.2. Europe
5.5.3. Asia Pacific
5.5.4. Latin America
5.5.5. Middle East and Africa
5.6. Market Size, & Forecasts, Volume and Trend Analysis, 2020 & 2028:
5.7. North America
5.7.1. Market estimates and forecast, 2016 - 2028 (USD Million)
5.7.2. U.S.
5.7.2.1. Market estimates and forecast, 2016 - 2028 (USD Million)
5.7.3. Canada
5.7.3.1. Market estimates and forecast, 2016 - 2028 (USD Million)
5.8. Europe
5.8.1. U.K.
5.8.1.1. Market estimates and forecast, 2016 - 2028 (USD Million)
5.8.2. Germany
5.8.2.1. Market estimates and forecast, 2016 - 2028 (USD Million)
5.9. Asia Pacific
5.9.1. Japan
5.9.1.1. Market estimates and forecast, 2016 - 2028 (USD Million)
5.9.2. China
5.9.2.1. Market estimates and forecast, 2016 - 2028 (USD Million)
5.9.3. India
5.9.3.1. Market estimates and forecast, 2016 - 2028 (USD Million)
5.10. Latin America
5.10.1. Brazil
5.10.1.1. Market estimates and forecast, 2016 - 2028 (USD Million)
5.10.2. Mexico
5.10.2.1. Market estimates and forecast, 2016 - 2028 (USD Million)
5.11. MEA
5.11.1. South Africa
5.11.1.1. Market estimates and forecast, 2016 - 2028 (USD Million)
Chapter 6. Competitive Landscape
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.1.1. Key company market share analysis, 2020
6.1.2. Medtronic PLC
6.1.2.1. Company Overview
6.1.2.2. Financial performance
6.1.2.3. Product Benchmarking
6.1.2.4. Strategic Initiatives
6.1.3. Cardio Medical GmbH
6.1.3.1. Company Overview
6.1.3.2. Financial performance
6.1.3.3. Product Benchmarking
6.1.3.4. Strategic Initiatives
6.1.4. GrenaLtd.
6.1.4.1. Company Overview
6.1.4.2. Financial performance
6.1.4.3. Product Benchmarking
6.1.4.4. Strategic Initiatives
6.1.5. Richard Wolf GmbH
6.1.5.1. Company Overview
6.1.5.2. Financial performance
6.1.5.3. Product Benchmarking
6.1.5.4. Strategic Initiatives
6.1.6. Intuitive Surgical, Inc.
6.1.6.1. Company Overview
6.1.6.2. Financial performance
6.1.6.3. Product Benchmarking
6.1.6.4. Strategic Initiatives
6.1.7. Dextera Surgical Inc.
6.1.7.1. Company Overview
6.1.7.2. Financial performance
6.1.7.3. Product Benchmarking
6.1.7.4. Strategic Initiatives
6.1.8. Teleflex Incorporated
6.1.8.1. Company Overview
6.1.8.2. Financial performance
6.1.8.3. Product Benchmarking
6.1.8.4. Strategic Initiatives
6.1.9. Medela Inc.
6.1.9.1. Company Overview
6.1.9.2. Financial performance
6.1.9.3. Product Benchmarking
6.1.9.4. Strategic Initiatives
6.1.10. LivaNova PLC
6.1.10.1. Company Overview
6.1.10.2. Financial performance
6.1.10.3. Product Benchmarking
6.1.10.4. Strategic Initiatives
6.1.11. Skylar Surgical Instruments
6.1.11.1. Company Overview
6.1.11.2. Financial performance
6.1.11.3. Product Benchmarking
6.1.11.4. Strategic InitiativesList of Tables
Table 1 List of Abbreviation
Table 2 North America Minimally Invasive Thoracic Surgery Market, by country, 2016 - 2028 (USD Million)
Table 3 North America Minimally Invasive Thoracic Surgery Market, by type, 2016 - 2028 (USD Million)
Table 4 U.S. Minimally Invasive Thoracic Surgery Market, by type, 2016 - 2028 (USD Million)
Table 5 Canada Minimally Invasive Thoracic Surgery Market, by type, 2016 - 2028 (USD Million)
Table 6 Europe Minimally Invasive Thoracic Surgery Market, by country, 2016 - 2028 (USD Million)
Table 7 Europe Minimally Invasive Thoracic Surgery Market, by type, 2016 - 2028 (USD Million)
Table 8 Germany Minimally Invasive Thoracic Surgery Market, by type, 2016 - 2028 (USD Million)
Table 9 U.K. Minimally Invasive Thoracic Surgery Market, by type, 2016 - 2028 (USD Million)
Table 10 Asia Pacific Minimally Invasive Thoracic Surgery Market, by country, 2016 - 2028 (USD Million)
Table 11 Asia Pacific Minimally Invasive Thoracic Surgery Market, by type, 2016 - 2028 (USD Million)
Table 12 Japan Minimally Invasive Thoracic Surgery Market, by type, 2016 - 2028 (USD Million)
Table 13 China Minimally Invasive Thoracic Surgery Market, by type, 2016 - 2028 (USD Million)
Table 14 India Minimally Invasive Thoracic Surgery Market, by type, 2016 - 2028 (USD Million)
Table 15 Latin America Minimally Invasive Thoracic Surgery Market, by country, 2016 - 2028 (USD Million)
Table 16 Latin America Minimally Invasive Thoracic Surgery Market, by type, 2016 - 2028 (USD Million)
Table 17 Mexico Minimally Invasive Thoracic Surgery Market, by type, 2016 - 2028 (USD Million)
Table 18 Brazil Minimally Invasive Thoracic Surgery Market, by type, 2016 - 2028 (USD Million)
Table 19 Middle East and Africa Minimally Invasive Thoracic Surgery Market, by country, 2016 - 2028 (USD Million)
Table 20 Middle East and Africa Minimally Invasive Thoracic Surgery Market, by type, 2016 - 2028 (USD Million)
Table 21 South Africa Minimally Invasive Thoracic Surgery Market, by type, 2016 - 2028 (USD Million)List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Minimally Invasive Thoracic Surgery Market: market outlook
Fig. 14 Minimally Invasive Thoracic Surgery Market competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Minimally Invasive Thoracic Surgery Market Driver Impact
Fig. 20 Minimally Invasive Thoracic Surgery Market Restraint Impact
Fig. 21 Minimally Invasive Thoracic Surgery Market Strategic Initiatives Analysis
Fig. 22 Minimally Invasive Thoracic Surgery Market: Type Movement Analysis
Fig. 23 Minimally Invasive Thoracic Surgery Market: Type outlook and key takeaways
Fig. 24 Lobectomy based market estimates and forecast, 2016 - 2028
Fig. 25 Wedge Resection based market estimates and forecast, 2016 - 2028
Fig. 26 Pneumonectomy based market estimates and forecast, 2016 - 2028
Fig. 27 Others based market estimates and forecast, 2016 - 2028
Fig. 28 Global Market Share and Leading Players
Fig. 29 North America Market Share and Leading Players
Fig. 30 Europe Market Share and Leading Players
Fig. 31 Asia Pacific Market Share and Leading Players
Fig. 32 Latin America Market Share and Leading Players
Fig. 33 Middle East & Africa Market Share and Leading Players
Fig. 34 North America: SWOT
Fig. 35 Europe SWOT
Fig. 36 Asia Pacific SWOT
Fig. 37 Latin America SWOT
Fig. 38 MEA SWOT
Fig. 39 North America, by country
Fig. 40 North America
Fig. 41 North America market estimates and forecast, 2016 - 2028
Fig. 42 U.S.
Fig. 43 U.S. market estimates and forecast, 2016 - 2028
Fig. 44 Canada
Fig. 45 Canada market estimates and forecast, 2016 - 2028
Fig. 46 Europe
Fig. 47 Europe. Market estimates and forecast, 2016 - 2028
Fig. 48 U.K.
Fig. 49 U.K. market estimates and forecast, 2016 - 2028
Fig. 50 Germany
Fig. 51 Germany market estimates and forecast, 2016 - 2028
Fig. 52 Asia Pacific
Fig. 53 Asia Pacific market estimates and forecast, 2016 - 2028
Fig. 54 China
Fig. 55 China market estimates and forecast, 2016 - 2028
Fig. 56 Japan
Fig. 57 Japan market estimates and forecast, 2016 - 2028
Fig. 58 India
Fig. 59 India market estimates and forecast, 2016 - 2028
Fig. 60 Latin America
Fig. 61 Latin America market estimates and forecast, 2016 - 2028
Fig. 62 Brazil
Fig. 63 Brazil market estimates and forecast, 2016 - 2028
Fig. 64 Mexico
Fig. 65 Mexico market estimates and forecast, 2016 - 2028
Fig. 66 Middle East and Africa
Fig. 67 Middle East and Africa. Market estimates and forecast, 2016 - 2028
Fig. 68 South Africa
Fig. 69 South Africa market estimates and forecast, 2016 - 2028
Fig. 70 Participant Categorization - Minimally Invasive Thoracic Surgery Market
Fig. 71 Market share of key market players - Minimally Invasive Thoracic Surgery Market
Companies Mentioned
- Medtronic PLC
- Cardio Medical GmbH
- GrenaLtd.
- Richard Wolf GmbH
- Intuitive Surgical, Inc.
- Dextera Surgical Inc.
- Teleflex Incorporated
- Medela Inc.
- LivaNova PLC
- Skylar Surgical Instruments
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 81 |
| Published | December 2021 |
| Forecast Period | 2021 - 2028 |
| Estimated Market Value ( USD | $ 3.1 Billion |
| Forecasted Market Value ( USD | $ 5.5 Billion |
| Compound Annual Growth Rate | 8.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
